Anemia in cervical cancer patients: Implications for iron supplementation therapy

Medical Oncology

Volumn 22, Issue 2, 2005, Pages 161-168

  Candelaria, Myrna ^a   Cetina, Lucely ^a   Dueñas González, Alfonso ^a,b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Anemia; Cervical cancer; Iron

Indexed keywords

CISPLATIN; IRON;

ADULT; ANEMIA; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IRON DEFICIENCY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANEMIA, IRON-DEFICIENCY; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DIETARY SUPPLEMENTS; FEMALE; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 22344449466     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:22:2:161     Document Type: Article

References (54)

1. Duenas-Gonzalez A, Cetina L, Mariscal I, de la Garza J. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev 2003;29:389-399.
2. Black AK, Allen LH, Pelto GH, de Mata MP, Chavez A. Iron, vitamin B-12 and folate status in Mexico: associated factors in men and women and during pregnancy and lactation. J Nutr 1994;124:1179-1188.
3. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997;277:973-976.
4. Evans JC, Bergsjø P. Influence of anemia on the results of radiation therapy in carcinoma of the cervix. Radiology 1965;84:709-716.
5. Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. The Oncologist 2002;7:492-508.
6. Mundt AJ, et al. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol 1998;71:151-158.
7. Takeshi K, et al. Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiat Oncol Biol Phys 1998;41:319-327.
8. Hong J-H, et al. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys 1998;41:823-830.
9. Kagei K, et al. High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix. Radiother Oncol 1998;47:207-213.
10. Lee WR, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998;42:1069-1075.
11. Pedersen D, Søgaard H, Overgaard J, Bentzen SM. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol 1995;34:787-795.
12. Girinski T, et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989;16:37-42.
13. Vigario G, Kurohara SS, George FW III. Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer. Radiology 1973;106:649-652.
14. Surgenor DM, Wallace EL, Hao SHS, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990;322:1646-1651.
15. Overgaard J. Sensitization of hypoxic tumour cells - clinical experience. Int J Radiat Biol 1989;56:801-811.
16. Azuma C, et al. The influence of peri-operative blood transfusion during radical hysterectomy on the prognosis of uterine cervical cancer. Transfus Sci 1997;18:55-62.
17. Eisenkop SM, et al. The clinical significance of blood transfusion at the time of radical hysterectomy. Obstet Gynecol 1990;76:110-113.
18. Lavey RS, Dempsey WH. Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:1147-1152.
19. Dusenbery KE, et al. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 1994;29:1079-1084.
20. Henke M, Guttenberger R. Erythropoietin in radiation oncology - a review. 1st international conference, Freiburg, June 11-12, 1999. Oncology 2000;58:175-182.
21. Sweeney PJ, et al. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial. Br J Cancer 1998;77:1996-2002.
22. Saxena S, Rabinowitz AP, Johnson C, Shulman IA. Iron-deficiency anemia: a medically treatable chronic anemia as a model for transfusion overuse. Am J Med 1993;94:120-124.
23. Pearcey R, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002;20:966-972.
24. Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncol 2001;28:60-65.
25. Dudrick SJ, O'Donnell JJ, Matheny RG, Unkel SP, Raleigh DP. Stimulation of hematopoiesis as an alternative to transfusion. South Med J 1986;79:669-673.
26. Dudrick SJ, O'Donnell JJ, Raleigh DP, Matheny RG, Unkel SP. Rapid restoration of red blood cell mass in severely anemic surgical patients who refuse transfusion. Arch Surg 1985;120:721-727.
27. Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;34:286-290.
28. Sharma JB, et al. A prospective, partially randomized study of pregnancy outcomes and hematologic responses to oral and intramuscular iron treatment in moderately anemic pregnant women. Am J Clin Nutr 2004;79:116-122.
29. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329:9-22.
30. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-260.
31. Nilsson KR, et al. Preoperative predictors of blood transfusion in colorectal cancer surgery. J Gastrointest Surg 2002;6:753-762.
32. Takemura M, Osugi H, Takada N, Kinoshita H, Higashino M. Immunologic effects of allogeneic versus autologous blood transfusion in patients undergoing radical oesophagectomy. Eur Surg Res 2003;35:115-122.
33. Pysz M. Blood transfusions in breast cancer patients undergoing mastectomy: possible importance of timing. J Surg Oncol 2000;75:258-263.
34. Nosotti M, et al. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Chest 2003;124:102-107.
35. Asahara T, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999;23:676-680.
36. Taniguchi Y, Okura M. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Head Neck 2003;25:931-936.
37. Blumberg N, Agarwal MM, Chuang C. A possible association between survival time and transfusion in cervical cancer. Yale J Biol Med 1988;61:493-500.
38. Vallejo RR, Hord ED, Barna SA, Santiago-Palma J, Ahmed S. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol 2003;22:139-146.
39. Vansteenkiste J, et al. Aranesp 980297 Study Group. Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy. J Natl Cancer Inst 2002;94:1211-1220.
40. Dunphy FR, et al. Erythropoietin reduces anemia and transfusions: a randomized trial with or without erythropoietin during chemotherapy. Cancer 1999;86:1362-1367.
41. Wurnig C, et al. Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study). Transfusion 1996;36:155-159.
42. Acs G, et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 2003;162:1789-1806.
43. Yasuda Y, et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003;24:1021-1029.
44. Yasuda Y, et al. Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice. Br J Cancer 2001;84:836-843.
45. Wun T, et al. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation and erythropoietin. Cancer 2003;98:1514-1520.
46. Henke M, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-1260.
47. Leyland-Jones B. BEST Investigators and Study Group. Breast cancer: trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003;4:459-460.
48. Flies AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anemia, hypoxia and transfusion in patients with cervix cancer. Radiother Oncol 2000;57:13-19.
49. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 2004;36:1-12.
50. Semenza GL. Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med 2002;41:79-83.
51. Srinivas V, Zhu X, Salceda S, Nakamura R, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) is a nonheme iron protein. Implications for oxygen sensing. J Biol Chem 1999;274:1180-1184.
52. Jeong HJ, et al. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun 2003;306:805-811.
53. Obralic N, Bilenjki D, Bilbija Z. Prognostic importance of anemia related parameters in patients with carcinoma of the cervix uteri. Acta Oncol 1990;29:199-201.
54. Auerbach M, et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 2004;22:1301-1307.